On April 13, 2025, the European Conference on Interventional Oncology (ECIO 2025) grandly opened in Rotterdam, the Netherlands. This top-tier academic event in the global field of interventional oncology treatment provided LEAPMED with an excellent stage to showcase its capabilities, allowing the world to witness the unique charm and robust strength of Chinese medical technology.
Since its establishment in 2008, ECIO has consistently been one of the most influential academic conferences in the field of interventional oncology treatment worldwide. Every year, it gathers top experts and industry elites from around the globe to jointly explore the future development of interventional oncology treatment through a multidisciplinary team (MDT) approach, propelling the field to new heights.
Since its inception, LEAPMED has been committed to providing comprehensive solutions in the ultrasound interventional industry and has been deeply involved in the field for over a decade. Currently, the company has obtained over 170 domestic and international patents (including 2 US invention patents, 6 European patents, and 14 domestic invention patents) and more than 20 global certification systems such as ISO13485 (CE-MDR), US QSR820 (FDA), KGMP (South Korea), PMDA (Japan), UKCA (UK), HSA (Singapore), and MDA (Malaysia). Additionally, LEAPMED boasts a nearly 100-member high-quality, international product development and marketing team dedicated to providing customers with superior products and services.
At this year's ECIO conference, LEAPMED showcased its latest interventional oncology products. The series of disposable biopsy needles not only feature a more user-friendly design that enhances operational convenience for physicians but also represent a significant breakthrough in performance, offering more precise and safer solutions for interventional oncology diagnosis and treatment. The disposable drainage catheter kit employs advanced materials and technologies to ensure precise catheter positioning under ultrasound guidance. With a pigtail design, built-in locking wire, reinforced tip to prevent displacement during puncture, hydrophilic coating for smoother puncture, and a sealing ring design to prevent leakage, it is suitable for drainage in the liver, kidneys, abdominal cavity, thoracic cavity, and bile ducts. It comes with a complete configuration to support both one-step and two-step puncture drainage methods.
LEAPMED success is not only attributed to its own technological innovation and R&D capabilities but also inseparable from the strong support of the state for medical technology. In recent years, China has made significant strides in the field of medical technology, with an increasing number of domestic medical devices making their way onto the global stage, offering better treatment options for patients worldwide.
Looking ahead, LEAPMED will continue to increase its R&D investment in the field of interventional oncology treatment, continuously enhancing the technological level and quality of its products. Guided by patient needs, we are committed to developing safer, more efficient, and more precise interventional oncology treatment products, bringing an even more outstanding treatment experience to patients worldwide. LEAPMED, with technology as its wings, is poised to help propel global interventional oncology treatment to new heights of excellence!
